Items where authors include "Catto, J.W.F."
![[up]](/style/images/multi_up.png)
Up a levelArticle
Conroy, S. orcid.org/0000-0001-7167-4908, Jubber, I., Noon, A.P. et al. (11 more authors) (2025) Real-word outcomes for high-risk non-muscle-invasive bladder cancer: screened patients for the BRAVO trial. BJU International, 135 (2). pp. 329-338. ISSN 1464-4096
Mandrik, O. orcid.org/0000-0003-3755-3031, Thomas, C. orcid.org/0000-0001-8704-3262, Akpan, E. et al. (2 more authors) (2025) Home urine dipstick screening for bladder and kidney cancer in high-risk populations in England: a microsimulation study of long-term impact and cost-effectiveness. PharmacoEconomics. ISSN 1170-7690
Powles, T., Catto, J.W.F. orcid.org/0000-0003-2787-8828, Galsky, M.D. et al. (22 more authors) (2024) Perioperative durvalumab with neoadjuvant chemotherapy in operable bladder cancer. New England Journal of Medicine, 391 (19). pp. 1773-1786. ISSN 0028-4793
Absolom, K., Rogers, Z., Catto, J.W.F. et al. (4 more authors) (2024) Decision regret regarding treatment choices one year after a new diagnosis of bladder cancer. European Urology, 86 (3). pp. 286-288. ISSN 0302-2838
Dhar, A. orcid.org/0000-0001-6739-6052, Siriwardana, A. orcid.org/0000-0002-6094-1246, Schofield, E. et al. (1 more author) (2024) Blood transfusion, radical cystectomy, and cancer recurrence: a new look at an old story. Comment on Ladner et al. Perioperative blood transfusion is associated with worse survival in patients undergoing radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer. Soc. Int. Urol. J. 2024, 5, 202–213. Société Internationale d’Urologie Journal, 5 (3). pp. 244-246. ISSN 2563-6499
Rogers, Z., Glaser, A., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (17 more authors) (2024) Health‐related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year. BJU International, 133 (4). pp. 460-473. ISSN 1464-4096
Griffin, J. orcid.org/0000-0003-3969-7637, Down, J., Quayle, L.A. et al. (10 more authors) (2024) Verification of molecular subtyping of bladder cancer in the GUSTO clinical trial. The Journal of Pathology: Clinical Research, 10 (2). e12363. ISSN 2056-4538
Rogers, Z., Glaser, A., Catto, J.W.F. et al. (17 more authors) (2023) Quality of life after a diagnosis of Bladder Cancer: Longitudinal survey over the first year. BJU International. ISSN 1464-4096
Nanton, V. orcid.org/0000-0002-9553-822X, Bryan, R.T. orcid.org/0000-0003-2853-4293, Pope, A.M. et al. (11 more authors) (2023) Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action. BMJ Oncology, 2 (1). e000092. ISSN 2752-7948
Conroy, S. orcid.org/0000-0001-7167-4908, Catto, J.W.F. orcid.org/0000-0003-2787-8828, Bex, A. et al. (11 more authors) (2023) Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019. BJU International, 132 (5). pp. 541-553. ISSN 1464-4096
Catto, J.W.F. orcid.org/0000-0003-2787-8828, North, B., Goff, M. et al. (6 more authors) (2023) Protocol for the YORKSURe prospective multistage study testing the feasibility for early detection of bladder cancer in populations with high disease-specific mortality risk. BMJ Open, 13 (9). e076612. ISSN 2044-6055
Jubber, I. orcid.org/0000-0002-4558-2521, Morhardt, D.R., Griffin, J. orcid.org/0000-0003-3969-7637 et al. (10 more authors) (2023) Analysis of the distal urinary tract in larval and adult zebrafish reveals homology to the human system. Disease Models & Mechanisms, 16 (7). dmm050110. ISSN 1754-8403
Dixon, S., Hill, H. orcid.org/0000-0002-0908-5595, Flight, L. et al. (47 more authors) (2023) Cost-effectiveness of robot-assisted radical cystectomy vs open radical cystectomy for patients with bladder cancer. JAMA Network Open, 6 (6). e2317255. ISSN 2574-3805
Mandrik, O. orcid.org/0000-0003-3755-3031, Hahn, A.I., Catto, J.W.F. et al. (3 more authors) (2023) Critical appraisal of decision models used for the economic evaluation of bladder cancer screening and diagnosis: a systematic review. PharmacoEconomics, 41 (6). pp. 633-650. ISSN 1170-7690
Catto, J.W.F. orcid.org/0000-0003-2787-8828, Mandrik, O. orcid.org/0000-0003-3755-3031, Quayle, L.A. et al. (12 more authors) (2023) Diagnosis, treatment and survival from bladder, upper urinary tract and urethral cancers: real-world findings from NHS England between 2013 and 2019. BJU International, 131 (6). pp. 734-744. ISSN 1464-4096
Bryant, R.J. orcid.org/0000-0002-8330-9251, Yamamoto, H. orcid.org/0000-0003-0831-9174, Eddy, B. et al. (26 more authors) (2023) Protocol for the TRANSLATE prospective, multicentre, randomised clinical trial of prostate biopsy technique. BJU International, 131 (6). pp. 694-704. ISSN 1464-4096
Cooper, O.A.E., Ghatnekar, O., Piglowska, N. et al. (5 more authors) (2023) Elicitation of health state utilities associated with progression from Bacillus Calmette-Guerin (BCG) unresponsive Non-muscle Invasive Bladder Cancer (NMIBC). PharmacoEconomics - Open, 7 (3). pp. 469-477. ISSN 2509-4262
Conroy, S., Pang, K., Jubber, I. et al. (5 more authors) (2023) Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients. BJUI Compass, 4 (3). pp. 314-321. ISSN 2688-4526
Hof, J.P., Vermeulen, S.H., van der Heijden, A.G. et al. (8 more authors) (2023) An association study of germline variants in bladder cancer-related genes with the prognosis of on-Muscle Invasive Bladder Cancer. Bladder Cancer, 9 (1). pp. 59-71. ISSN 2352-3727
Lane, J.A., Donovan, J.L., Young, G.J. et al. (26 more authors) (2022) Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study). BJU International, 130 (3). pp. 370-380. ISSN 1464-4096
Jubber, I., Rogers, Z., Catto, J.W.F. et al. (4 more authors) (2022) Sexual activity, function and dysfunction after a diagnosis of bladder cancer. The Journal of Sexual Medicine, 19 (9). pp. 1431-1441. ISSN 1743-6095
Conroy, S., Hubbard, R., Noon, A.P. et al. (4 more authors) (2022) Case of the month from the University of Sheffield, UK : expediting definitive treatment in patients with invasive bladder cancer : an MRI-guided pathway. BJU International, 129 (6). pp. 691-694. ISSN 1464-4096
Griffin, J. orcid.org/0000-0003-3969-7637, Chen, Y., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (1 more author) (2022) Gene of the month: NKX3.1. Journal of Clinical Pathology, 75 (6). pp. 361-364. ISSN 0021-9746
Hussain, S.A. orcid.org/0000-0003-1552-511X, Lester, J.F., Jackson, R. et al. (17 more authors) (2022) Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE) : a double-blind, randomised, phase 2 trial. The Lancet Oncology, 23 (5). pp. 650-658. ISSN 1470-2045
Galesloot, T.E., Grotenhuis, A.J., Kolev, D. et al. (16 more authors) (2022) Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non–muscle-invasive bladder cancer. European Urology Oncology, 5 (1). pp. 70-83. ISSN 2588-9311
Tan, W.S., Leow, J.J., Marchese, M. et al. (10 more authors) (2021) Defining factors associated with high-quality surgery following radical cystectomy : analysis of the British Association of Urological Surgeons cystectomy audit. European Urology Open Science, 33. pp. 1-10. ISSN 2666-1683
Tamhankar, A.S., Thurtle, D., Hampson, A. et al. (7 more authors) (2021) Radical cystectomy in England from 2013 to 2019 on 12,644 patients : an analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data. BJUI Compass, 2 (5). pp. 338-347.
Shariat, S., Gontero, P. and Catto, J.W.F. orcid.org/0000-0003-2787-8828 (2021) How to treat a patient with T1 high-grade disease and no tumour on repeat transurethral resection of the bladder? European Urology Oncology, 4 (4). pp. 663-669. ISSN 2588-9311
Catto, J.W.F. orcid.org/0000-0003-2787-8828, Downing, A., Mason, S. et al. (9 more authors) (2021) Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes. European Urology, 79 (5). pp. 621-632. ISSN 0302-2838
Crabb, S.J., Danson, S. orcid.org/0000-0002-3593-2890, Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (16 more authors) (2021) Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE). Clinical Cancer Research, 27 (7). pp. 1882-1892. ISSN 1078-0432
Catto, J.W.F. orcid.org/0000-0003-2787-8828, Gordon, K., Collinson, M. et al. (14 more authors) (2021) Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study. Journal of Clinical Oncology, 39 (3). pp. 202-214. ISSN 0732-183X
Del Giudice, F.D., Pecoraro, M., Vargas, H.A. et al. (8 more authors) (2020) Systematic review and meta-analysis of vesical imaging-reporting and data system (VI-RADS) inter-observer reliability : an added value for muscle invasive bladder cancer detection. Cancers, 12 (10). 2994.
Noble, S.M., Garfield, K., Lane, J.A. et al. (24 more authors) (2020) The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer. British Journal of Cancer, 123 (7). pp. 1063-1070. ISSN 0007-0920
Ürün, Y., Hussain, S.A. orcid.org/0000-0003-1552-511X, Bakouny, Z. et al. (13 more authors) (2020) Survey of the impact of COVID-19 on oncologists’ decision making in cancer. Jco Global Oncology, 6. pp. 1248-1257. ISSN 2687-8941
Leow, J.J., Catto, J.W.F. orcid.org/0000-0003-2787-8828, Efstathiou, J.A. et al. (8 more authors) (2020) Quality indicators for bladder cancer services : a collaborative review. European Urology, 78 (1). pp. 43-59. ISSN 0302-2838
Mostafid, A.H., Porta, N., Cresswell, J. et al. (14 more authors) (2020) CALIBER - A phase II randomised feasibility trial of chemoablation with mitomycin versus surgical management in low risk non-muscle invasive bladder cancer. BJU International, 125 (6). pp. 817-826. ISSN 1464-4096
Birtle, A., Johnson, M., Chester, J. et al. (21 more authors) (2020) Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial. The Lancet, 395 (10232). pp. 1268-1277. ISSN 0140-6736
Williams, S.B., Ray-Zack, M.D., Hudgins, H.K. et al. (7 more authors) (2019) Impact of centralizing care for genitourinary malignancies to high-volume providers: a systematic review. European Urology Oncology, 2 (3). pp. 265-273. ISSN 2588-9311
McNeill, R.V., Mason, A.S., Hodson, M.E. et al. (2 more authors) (2019) Specificity of the metallothionein-1 response by cadmium-exposed normal human urothelial cells. International Journal of Molecular Sciences, 20 (6). 1344. ISSN 1661-6596
Downing, A., Wright, P., Hounsome, L. et al. (23 more authors) (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncology, 20 (3). pp. 436-447. ISSN 1470-2045
Cumberbatch, M.G.K., Jubber, I., Black, P.C. et al. (9 more authors) (2018) Epidemiology of bladder cancer: A systematic review and contemporary update of risk factors in 2018. European Urology, 74 (6). pp. 784-795. ISSN 0302-2838
Mason, S.J. orcid.org/0000-0003-0306-8353, Catto, J.W.F. orcid.org/0000-0003-2787-8828, Downing, A. et al. (3 more authors) (2018) Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU International, 122 (5). pp. 760-773. ISSN 1464-4096
Donnelly, D.W., Donnelly, C., Kearney, T. et al. (26 more authors) (2018) Urinary, bowel and sexual health in older men from Northern Ireland. BJU International, 122 (5). pp. 845-857. ISSN 1464-4096
Panebianco, V., Narumi, Y., Altun, E. et al. (15 more authors) (2018) Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). European Urology, 74 (3). pp. 294-306.
Catto, J.W.F., Khetrapal, P., Ambler, G. et al. (12 more authors) (2018) Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study. BMJ Open, 8 (8). e020500.
Cumberbatch, M.G.K., Foerster, B., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (6 more authors) (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. European Urology, 73 (6). pp. 925-933. ISSN 0302-2838
Melling, G.E., Flannery, S.E., Abidin, S.A. et al. (13 more authors) (2018) A miRNA-145/TGF-β1 Negative Feedback Loop Regulates the Cancer-Associated Fibroblast Phenotype. Carcinogenesis, 39 (6). pp. 798-807. ISSN 0143-3334
Obajemu, O., Mahfouf, M. and Catto, J.W.F. (2018) A new fuzzy modeling framework for integrated risk prognosis and therapy of bladder cancer patients. IEEE Transactions on Fuzzy Systems, 26 (3). pp. 1565-1577. ISSN 1063-6706
Crabb, S., Danson, S.J., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (12 more authors) (2018) SPIRE - combining SGI-110 with cisplatin and gemcitabine chemotherapy for solid malignancies including bladder cancer: study protocol for a phase Ib/randomised IIa open label clinical trial. Trials, 19. 216. ISSN 1745-6215
Pang, K.H., Groves, R., Venugopal, S. et al. (2 more authors) (2018) Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. European Urology, 73 (3). pp. 363-371. ISSN 0302-2838
Cumberbatch, M.G. and Catto, J.W.F. orcid.org/0000-0003-2787-8828 (2018) Re: Comprehensive Molecular Characterization of Muscle Invasive Bladder Cancer. European Urology, 73 (3). pp. 479-480. ISSN 0302-2838
Oughton, J.B. orcid.org/0000-0002-2047-804X, Poad, H., Twiddy, M. et al. (14 more authors) (2017) Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study. BMJ Open, 7 (8). e017913.
MacLennan, S.J., MacLennan, S., Bex, A. et al. (10 more authors) (2017) Changing current practice in urology: Improving guideline development and implementation through stakeholder engagement. European Urology, 72 (2). pp. 161-163. ISSN 0302-2838
Catto, J.W.F. orcid.org/0000-0003-2787-8828 (2017) Speeding up recovery from radical cystectomy: how low can we go? BJU International , 120 (2). pp. 162-163. ISSN 1464-4096
Catto, J.W.F. orcid.org/0000-0003-2787-8828, Blazeby, J.M., Holmberg, L. et al. (2 more authors) (2017) In Defense of Randomized Clinical Trials in Surgery: Let Us Not Forget Archie Cochrane's Legacy. European Urology, 71 (5). pp. 820-821. ISSN 0302-2838
Pang, K.H., Rosario, D.J., Morgan, S.L. et al. (1 more author) (2017) Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies. PLoS One, 12 (4). e0175070.
Edmondson, A.J., Birtwistle, J.C., Catto, J.W.F. et al. (1 more author) (2017) The patients' experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence. Journal of Cancer Survivorship. ISSN 1932-2259
Bryan, R.T., Evans, T., Dunn, J.A. et al. (6 more authors) (2015) A Comparative Analysis of the Influence of Gender, Pathway Delays, and Risk Factor Exposures on the Long-term Outcomes of Bladder Cancer. European Urology Focus, 1 (1). 82 - 89.
Boström, P.J., Bjartell, A.S., Catto, J.W.F. et al. (6 more authors) (2015) Genomic Predictors of Outcome in Prostate Cancer. European Urology, 68 (6). pp. 1033-1044. ISSN 0302-2838
Yuh, B., Wilson, T., Bochner, B. et al. (9 more authors) (2015) Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. European Urology, 67 (3). 402 - 422. ISSN 0302-2838
Novara, G., Catto, J.W.F., Wilson, T. et al. (9 more authors) (2015) Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. European Urology, 67 (3). 376 - 401. ISSN 0302-2838
Drayton, R.M., Rehman, I., Clarke, R. et al. (13 more authors) (2015) Identification and Diagnostic Performance of a Small RNA within the PCA3 and BMCC1 Gene Locus That Potentially Targets mRNA. Cancer Epidemiology, Biomarkers and Prevention, 24 (1). 268 - 275. ISSN 1055-9965
Borkowska, E.M., Kruk, A., Jedrzejczyk, A. et al. (11 more authors) (2014) Molecular subtyping of bladder cancer using Kohonen self-organizing maps. Cancer Medicine, 3 (5). pp. 1225-1234.
Wang, W.T., Catto, J.W.F. and Meuth, M. (2014) Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors. Oncogene, 34 (22). 2887 - 2896. ISSN 0950-9232
Drayton, R.M., Peter, S., Myers, K. et al. (4 more authors) (2014) MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. Oncotarget, 5 (15). pp. 6375-6386.
Drayton, R.M., Dudziec, E., Peter, S. et al. (4 more authors) (2014) Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11. Clinical Cancer Research, 20 (7). pp. 1990-2000. ISSN 1078-0432
Noon, A.P., Albertsen, P.C., Thomas, F. et al. (2 more authors) (2013) Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. British Journal of Cancer , 108 (7). pp. 1534-1540. ISSN 0007-0920
Miah, S., Dudziec, E., Drayton, R.M. et al. (5 more authors) (2012) An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. British Journal of Cancer, 107 (1). pp. 123-128. ISSN 0007-0920
Bryant, R.J., Pawlowski, T., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (6 more authors) (2012) Changes in circulating microRNA levels associated with prostate cancer. British Journal of Cancer, 106 (4). pp. 768-774. ISSN 0007-0920
Catto, J.W.F., Abbod, M.F., Wild, P.J. et al. (10 more authors) (2010) The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. European Urology, 57 (3). pp. 398-406. ISSN 0302-2838
Rehman, I., Cross, S.S. orcid.org/0000-0003-2044-1754, Azzouzi, A.R. et al. (7 more authors) (2004) S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. British Journal of Cancer, 91. pp. 739-744. ISSN 0007-0920
Calvert, N.W., Morgan, A.B., Catto, J.W.F. orcid.org/0000-0003-2787-8828 et al. (4 more authors) (2003) Effectiveness and cost-effectiveness of prognostic markers in prostate cancer. British Journal of Cancer, 88. pp. 31-35. ISSN 0007-0920
Proceedings Paper
Crabb, S.J., Hussain, S.A., Oughton, J.B. et al. (15 more authors) (2024) Use of gene expression patterns to identify unique molecular subtypes in muscle invasive bladder cancer: GUSTO. In: Journal of Clinical Oncology. 2024 ASCO Annual Meeting, 31 May - 04 Jun 2024, Chicago, USA. American Society of Clinical Oncology .